Foghorn Therapeutics Inc. (FHTX) Total liabilities 2020–2025
Foghorn Therapeutics Inc. (FHTX) total liabilities at each fiscal year-end, per SEC filings.
$306.6MFY2025 · since FY2020: $109.4M → $306.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $306.6M | -7.0% |
| FY2024 | $329.5M | -9.3% |
| FY2023 | $363.1M | -10.3% |
| FY2022 | $404.8M | -4.3% |
| FY2021 | $422.9M | +286.5% |
| FY2020 | $109.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More FHTX financial trends
FHTX RevenueFHTX Net incomeFHTX Net marginFHTX Gross profitFHTX Gross marginFHTX Operating incomeFHTX Operating marginFHTX Operating cash flowFHTX Free cash flowFHTX Capital expendituresFHTX Return on equityFHTX Stock buybacksFHTX Dividends paidFHTX Total assetsFHTX Shareholders’ equityFHTX overview →